All Articles

Despite a Q1 net loss, Mach Natural Resources boosts its cash distribution and shifts capital to oil, signaling confidence in its operational strength.

The cloud company's results show modest growth, but a strategic pivot to shed a recent acquisition and focus on its 'Dash' AI tool is paying off.

The AI data protection leader smashed Q1 estimates, raising its full-year outlook as demand for AI governance solutions fuels record revenue and profitability.

With its Q1 earnings call looming, Dollar Tree faces intense scrutiny over its new pricing strategy and what its results signal about consumer health.

Aptar Pharma and the FDA lead a critical mission to reinvent respiratory medicine, ensuring patient safety while tackling the climate impact of inhalers.

The biotech supplier swung to profitability and positive cash flow, driven by a major cost overhaul and strong demand in its core nucleic acid business.

AdCare Rhode Island consolidates services in North Kingstown, creating an integrated care hub to tackle addiction in one of the state's most underserved regions.

The LGBTQ+ app reports record Q1 earnings and plans a premium 'Edge' service, but faces growing challenges with data privacy and anti-gay policies.

The chipmaker topped Q1 estimates and eyes a strong Q2, fueled by EV and AI markets, even as restructuring charges weigh on its bottom line.

With a strong balance sheet and promising data, Enliven Therapeutics is pushing its lead leukemia drug, ELVN-001, into a pivotal late-stage trial.

As insurers invest billions in opaque private loans, state and federal officials are coordinating to manage hidden risks for policyholders and the financial system.

State investments yield a record number of new teachers, but experts warn of a looming retention crisis fueled by burnout and low pay.

With its stock at an all-time high, Ross Stores' upcoming earnings will be a critical test for the off-price sector's resilience and consumer spending.

Semiconductor giant KLA announces a massive stock split and a 21% dividend hike, rewarding shareholders and making its stock more accessible to all.

Artivion posts strong Q1 results and acquires Endospan for its FDA-approved NEXUS system, yet lowers its full-year guidance. What's behind the mixed message?

As Talphera preps its Q1 update, all eyes are on its breakthrough drug Niyad® and the mounting costs of bringing a potential game-changer to market.

The private energy giant posted $171M in free cash flow, cut debt, and earned a Fitch upgrade, signaling robust health amid market volatility.

With a May 22 deadline, conservation groups are racing to apply for a share of $160 million dedicated to protecting Minnesota's natural legacy.

Job applications have tripled, but your chance of an interview is down 50%. New data reveals how AI is creating a tougher, more selective hiring market.

Carrington acquires Valon Mortgage and adopts its AI platform, a landmark deal set to redefine the complex world of government mortgage servicing.